Fig. 2From: Riboflavin prophylaxis in pediatric and adolescent migraineMean headache frequency: comparison between Phase 1 and, respectively, Phase 2 (P < 0.01), Phase 2a (P < 0.01), Phase 2b (P > 0.05), Phase 3 (P < 0.01)Back to article page